Anoro Ellipta® (umeclidinium and vilanterol) is a prescription medication used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. This inhalation powder combines two active ingredients: umeclidinium, a long-acting anticholinergic (LAMA), and vilanterol, a long-acting beta-agonist (LABA). Together, they work to relax and open the airways, making it easier to breathe and reducing COPD symptoms such as shortness of breath, wheezing, and chronic cough.

Features:

• Dual-Action Formula: Anoro Ellipta® combines a LAMA (umeclidinium) and a LABA (vilanterol) in a single inhaler, providing enhanced, long-lasting bronchodilation for the treatment of COPD.

• FDA-Approved: Approved by the FDA for the maintenance treatment of COPD in adults. It is not intended for use in the management of acute bronchospasm or asthma.

• Convenient Once-Daily Dosing: Anoro Ellipta® is designed to be taken once a day, providing continuous relief from COPD symptoms for a full 24 hours.

• Proven Effectiveness: Clinically proven to improve lung function and reduce the frequency of COPD exacerbations.